Real-time enrollment status for this chemotherapy-induced thrombocytopenia clinical trial
Current Status
Active, Not Recruiting
Checked: April 17, 2026 at 2:15 AM UTC
| NCT Number | NCT03937154 |
| Recruiting Status | Active, Not Recruiting |
| Condition | Chemotherapy-induced thrombocytopenia |
| Phase | Clinical Trial |
| Target Enrollment | 162 participants |
| Active Locations | 27 sites in the US |
| Sponsor | Amgen |
| Last Updated on CT.gov | April 7, 2026 (1 week ago) |
As of April 17, 2026: Clinical trial NCT03937154 is currently active_not_recruiting participants. This clinical trial study for chemotherapy-induced thrombocytopenia is not currently accepting new participants at 27 locations across the United States. The study is sponsored by Amgen. This status information is automatically verified from the official ClinicalTrials.gov registry.
No, NCT03937154 is currently active_not_recruiting. The study may resume recruiting in the future.
This trial is recruiting at 27 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT03937154 was last updated 1 week ago (April 7, 2026). HelloStudys verifies this status automatically.